MXCT
MAXCYTE, INC.
+0.05 (+3.81%)1.23USD79.6K成交股數126M市值–本益比(近四季)6.7股價營收比-15.3%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 4.9M-14% | 4.5M-26% | 4.6M-18% | 5.8M+17% | 5.7M+3% | 6.1M+46% | 5.6M-0% | 5.0M+0% | 5.6M | 4.2M | 5.6M | 5.0M |
| 營業成本 | 1.7M | 1.6M | 1.6M | 1.5M | 1.5M | 2.3M | 1.9M | 1.5M | 1.4M | 793K | 1.4M | 1.0M |
| 毛利 | 5.6M-37% | 8.1M+26% | 5.2M-16% | 7.0M-22% | 8.9M-11% | 6.4M-11% | 6.2M-19% | 8.9M+18% | 9.9M | 7.2M | 7.7M | 7.6M |
| 毛利率 | 113.4% | 179.6% | 113.7% | 120.0% | 154.8% | 105.9% | 111.1% | 180.1% | 178.0% | 173.5% | 136.4% | 152.6% |
| 研發費用 | 4.3M | 3.9M | 5.3M | 6.3M | 5.9M | 4.6M | 5.3M | 5.6M | 6.7M | 6.3M | 5.7M | 6.0M |
| 銷售管理費用 | 7.3M | 6.0M | 6.0M | 8.1M | 8.5M | 7.2M | 7.7M | 7.6M | 7.1M | 6.8M | 7.7M | 7.5M |
| 營業利益 | −10.2M-17% | −6.2M-52% | −14.1M+1% | −14.2M+19% | −12.3M+0% | −12.9M-8% | −14.1M+7% | −12.0M-9% | −12.3M | −14.0M | −13.1M | −13.2M |
| 營業利益率 | -207.3% | -137.4% | -307.4% | -244.3% | -214.1% | -213.1% | -250.4% | -241.0% | -219.8% | -335.7% | -232.5% | -265.5% |
| 稅後淨利 | −8.9M-14% | −4.8M-55% | −12.4M+7% | −12.4M+32% | −10.3M+8% | −10.6M-6% | −11.6M+10% | −9.4M-14% | −9.5M | −11.3M | −10.5M | −10.9M |
| 淨利率 | -179.8% | -105.5% | -269.7% | -212.2% | -178.7% | -175.0% | -205.9% | -188.8% | -170.6% | -270.7% | -187.0% | -219.2% |
| 稀釋 EPS | -0.08-20% | -0.04 | -0.12+9% | -0.12+33% | -0.10 | – | -0.11+10% | -0.09-18% | – | -0.11 | -0.10 | -0.11 |
| 稀釋股數 | 107M | 107M | 107M | 106M | 106M | 105M | 105M | 105M | 104M | 103M | 103M | 103M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 15.0M | 14.6M | 13.0M | 15.2M | 23.4M | 27.9M | 37.0M | 37.5M | 22.2M | 49.2M | 54.6M | 37.8M |
| 應收帳款 | 3.9M | 4.2M | 8.3M | 5.8M | 5.5M | 4.7M | 4.6M | 4.6M | 6.0M | 8.2M | 7.6M | 8.3M |
| 存貨 | 7.8M | 7.6M | 7.6M | 7.9M | 8.3M | 8.9M | 10.4M | 11.2M | 12.0M | 12.5M | 11.0M | 10.3M |
| 總資產 | 185M | 194M | 213M | 220M | 230M | 239M | 249M | 251M | 258M | 267M | 271M | 282M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 25.9M | 26.6M | 33.2M | 29.0M | 30.5M | 33.2M | 35.3M | 30.2M | 31.6M | 33.4M | 30.2M | 33.7M |
| 股東權益 | 159M | 168M | 180M | 191M | 199M | 206M | 213M | 221M | 226M | 233M | 241M | 248M |
| 負債比 | 14.0% | 13.7% | 15.6% | 13.2% | 13.3% | 13.9% | 14.2% | 12.0% | 12.2% | 12.5% | 11.1% | 12.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.2M | – | – | −14.4M+36% | – | – | – | −10.6M | – | – | −4.3M |
| 資本支出 | – | 72K | – | – | 653K | – | – | – | 804K | – | – | 1.6M |
| 自由現金流 | – | −8.2M | – | – | −15.1M+33% | – | – | – | −11.4M | – | – | −5.9M |
| 折舊攤銷 | 953K | 1.0M | 1.0M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.0M | 962K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -183.1% | – | – | -262.3% | – | – | – | -203.6% | – | – | -118.5% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 33.0M
| Cell Engineering Technology | 33.0M | 100.0% | -14.5% |
|---|
地區2025 年度 · 33.0M
| 美國 | 21.1M | 63.8% | -18.2% |
|---|---|---|---|
| 美國以外 | 11.9M | 36.2% | -7.1% |
產品／服務2025 年度 · 33.0M
| 產品 | 18.7M | 56.6% | -11.4% |
|---|---|---|---|
| License | 12.4M | 37.5% | -24.6% |
| Assay And Other Service Revenue | 2.0M | 6.0% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 21.0M | -5.7% | −44.6M | -213.0% | -0.42 | −36.2M |
| FY2024 | 22.2M | +13.9% | −41.1M | -184.8% | -0.39 | −29.3M |
| FY2023 | 19.5M | -32.2% | −37.9M | -194.5% | -0.37 | −25.4M |
| FY2022 | 28.7M | +33.3% | −23.6M | -82.0% | -0.23 | −33.3M |
| FY2021 | 21.6M | +39.6% | −19.1M | -88.5% | -0.21 | −14.5M |
| FY2020 | 15.5M | +16.6% | −11.8M | -76.5% | -0.17 | −10.9M |
| FY2019 | 13.3M | – | −12.9M | -97.3% | -0.23 | −10.1M |